OHSS

Clinical trial pipeline · Data from ClinicalTrials.gov

See which OHSS trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

RecruitingPhase 2

NCT07043322

Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syn…

Ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication of controlled ovarian stimulation of gonadotrophin-Stimulated ovarian cycles. It i…

Egypt150 participantsStarted 2025-06-30

Treatment: Coasting, Cabergoline

RecruitingNot Applicable

NCT05173597

Real-world Evidence on Follitropin Delta Individual Dosing

As part of the in vitro fertilisation treatment, ovarian stimulation is routinely performed. For this purpose, FSH preparations are used. Follitropin delta is a…

Germany850 participantsStarted 2021-12-08

Treatment: Follitropin delta

RecruitingNot Applicable

NCT06739759

Ovarian Hyperstimulation Syndrome Prevention

Ovarian hyperstimulation is a very hazardous complication of ICSI

Egypt300 participantsStarted 2024-11-17

Treatment: Antagonist protocol for IVF, Modified Agonist protocol for IVF with additive treatments as HCQ

All recent trials (99 shown)

CompletedNot Applicable

NCT07568886

Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients

This study aims to evaluate whether the combination of Albumin and Furosemide can reduce the risk of Ovarian Hyperstimulation Syndrome in women undergoing intra…

Iraq200 participantsStarted 2019-04-29

Treatment: Albumin (Human) 20%, Furosemide

Not Yet RecruitingPhase 3

NCT07346235

150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial

This is a single-center, randomized, open-label, non-inferiority trial comparing two fixed daily doses of follicle-stimulating hormone (FSH): 150 IU versus 225…

Kosovo440 participantsStarted 2026-03-01

Treatment: Follicle-stimulating hormone (FSH), Follicle-stimulating hormone (FSH)

OHSS

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syn…

Real-world Evidence on Follitropin Delta Individual Dosing

Ovarian Hyperstimulation Syndrome Prevention

All recent trials (99 shown)

Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients

150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syn…

Real-world Evidence on Follitropin Delta Individual Dosing

Ovarian Hyperstimulation Syndrome Prevention

All recent trials (99 shown)

Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients

150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial

Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin

Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration

The Letrozole Administration During Luteal Phase

Freeze All Strategy Versus Fresh Embryo Transfer After GnRH Analogue Trigger

Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome

Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy

Montelukast for Prevention & Treatment of OHSS

Ovarian Hyperstimulation Syndrome Using Calcium Infusion

Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !?

The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

In Vitro Maturation (IVM) of Human Oocytes

Efficacy and Safety of Medication Used to Stimulate Ovulation

Medical Assistance for the Procreation and Risk of Thrombosis.

Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response

Comparison of Clinical Outcomes Between IVM and Minimal Stimulation IVF in Patients With PCOS